By Mill Chart
Last update: Mar 28, 2024
On Thursday, there are stocks with unusual volume. Let's take a look.
Ticker | Change | Comment |
---|---|---|
IBIO | 37.83% | Today's trading session witnessed an unusual volume of 43.25M shares for IBIO INC (NYSEARCA:IBIO). NYSEARCA:IBIO is showing a positive trend today, with a price increase of 37.83%. Today's trading volume is 1.0K% above the average 50-day volume, indicating a significant deviation from the norm. |
QH | 3.04% | So far 2.83M shares of QUHUO LTD-ADR (NASDAQ:QH) have traded in today's session. Shares are rising by 3.04%. With an average daily volume of 245.01K over the past 50 days, today's volume is 1.0K% above the average, indicating a potential shift in market sentiment. |
FLGC | 21.99% | 2.55M shares of FLORA GROWTH CORP (NASDAQ:FLGC) have been traded so far today. NASDAQ:FLGC is experiencing an advancement of 21.99% in its share price today. With an average volume of 649.79K over the past 50 days, the current volume is 293.0% above the average. This deviation signals a potential shift in market dynamics. |
CZOO | 7.56% | CAZOO GROUP LTD (NYSE:CZOO) has an unusual volume of 7.79M shares. Shares in NYSE:CZOO are on the rise, with a gain of 7.56% observed in today's trading session. The average volume measured over 50 days is 1.02M, so this is 665.0% above the average volume. |
MRDB | 11.5% | The trading activity for MARIADB PLC (NYSE:MRDB) has surged with a volume of 4.73M shares today. The market is favoring NYSE:MRDB today, as its share price records a notable increase of 11.5%. The current trading volume is 177.0% above the average 50-day volume. This indicates a significant deviation from the average trading activity. A press release (Announcement Regarding Possible Offer) was released earlier today. |
STOK | -7.87% | STOKE THERAPEUTICS INC (NASDAQ:STOK) has an unusual volume of 3.1M shares today. The share price decreased by 7.87%. This volume is 205.0% above the average 50 day volume. Yesterday the company had a press release: Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering. |
PAYS | -11.25% | Today, PAYSIGN INC (NASDAQ:PAYS) stands out with a high volume of 1.26M shares. The share price experienced a decrease of 11.25%. Compared to the average daily volume of the past 50 days, the current volume is 206.0% above, suggesting an unusual level of trading activity. |
DNUT | -1.24% | The trading activity for KRISPY KREME INC (NASDAQ:DNUT) has surged with a volume of 5.31M shares today. The share price experienced a decrease of 1.24%. The average volume over the last 50 days is 2.19M, making today's volume 143.0% above the average. This signifies a notable change in market participation. |
SINT | -1.98% | 6.34M shares of SINTX TECHNOLOGIES INC (NASDAQ:SINT) exchanged hands today. The price decline of 1.98% reflects a downward movement in NASDAQ:SINT shares. The average daily volume over 50 days is 4.34M, so this is 45.89% above the average volume. yesterday the company released their earnings. |
MESO | 38.97% | The stock of MESOBLAST LTD- SPON ADR (NASDAQ:MESO) has caught attention with a significant volume of 12.1M shares today. The share price of NASDAQ:MESO increased by 38.97% today, reflecting positive market movement. The average daily volume over 50 days is 1.95M, so this is 521.0% above the average volume. |
For the full unusual volume stocks list go to our unusual volume stocks screener.
IBIO INC
NYSEARCA:IBIO (4/22/2024, 7:07:27 PM)
Premarket: 1.72 -0.06 (-3.37%)1.78
+0.06 (+3.49%)
The healthcare industry is one of the most potent yet also one of the most competitive. This has short sellers out for blood.
Canada Goose layoffs are in the news Wednesday as the luxury apparel company prepares to cut 17% of its corporate employees.
Rent the Runway stock is falling on Wednesday after the company announced a one-for-20 reverse split for its shares coming in April.
IBIO stock is soaring after the firm announced that it would launch a partnership based on AI and obesity treatments.
– Leading AI and precision biologics innovators to build a diverse set of novel best-in-class obesity treatments – – iBio to use its patented generative...
– Purchase price of $2.85 represents a premium of 148+% to last close –
iBio shares surge as the biopharmaceutical company announces the sale of its preclinical PD-1 agonist antibody program to Otsuka Pharmaceutical, securing...
– Deal includes $1 million upfront and potential future milestone payments – – iBio’s proprietary therapeutic pipeline will now be comprised entirely of...
- VP of Platform Technologies, Matt Greving, to give podium presentation on enhancing bispecific T-cell engager discovery and development with machine...
iBio extends credit facility maturity date, providing more time for planned divestiture.
– Extends maturity date to March 29, 2024 – – Allows for more time to complete planned divestiture of legacy CDMO business - BRYAN, Texas and SAN...
Albemarle stock is falling on Tuesday alongside a downgrade and price target reduction for ALB shares from a Piper Sandler analyst.